Leo Wealth LLC Takes Position in CVS Health Corporation $CVS

Key Points

• Leo Wealth LLC has acquired a new stake in CVS Health Corporation, purchasing 7,793 shares valued at approximately $538,000.
• Insider activity revealed that Director Anne A. Finucane sold 7,500 shares, reducing her stake by 25.29% to 22,156 shares.
• CVS Health reported earnings of $1.81 EPS for the most recent quarter, surpassing expectations and generating revenue of $98.92 billion.

Leo Wealth LLC acquired a new stake in shares of CVS Health Corporation (NYSE:CVS - Free Report) during the 2nd quarter, according to its most recent disclosure with the SEC. The fund acquired 7,793 shares of the pharmacy operator's stock, valued at approximately $538,000.

Other large investors have also bought and sold shares of the company. Golden Reserve Retirement LLC bought a new stake in shares of CVS Health during the second quarter valued at approximately $468,000. Maryland State Retirement & Pension System boosted its position in shares of CVS Health by 3.2% during the second quarter. Maryland State Retirement & Pension System now owns 60,875 shares of the pharmacy operator's stock valued at $4,199,000 after purchasing an additional 1,891 shares in the last quarter. Optas LLC bought a new stake in shares of CVS Health during the second quarter valued at approximately $433,000. WESPAC Advisors LLC bought a new stake in shares of CVS Health during the 2nd quarter valued at $763,000. Finally, Venturi Wealth Management LLC bought a new stake in shares of CVS Health during the 2nd quarter valued at $259,000. 80.66% of the stock is owned by institutional investors.

Insider Buying and Selling at CVS Health

In other news, Director Anne A. Finucane sold 7,500 shares of the stock in a transaction on Wednesday, August 20th. The stock was sold at an average price of $71.02, for a total transaction of $532,650.00. Following the transaction, the director directly owned 22,156 shares of the company's stock, valued at $1,573,519.12. This represents a 25.29% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. 1.22% of the stock is owned by insiders.

CVS Health Trading Down 0.2%

Shares of NYSE:CVS opened at $76.78 on Friday. The company has a market cap of $97.38 billion, a P/E ratio of 21.45, a PEG ratio of 0.85 and a beta of 0.60. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.80 and a quick ratio of 0.62. CVS Health Corporation has a 1 year low of $43.56 and a 1 year high of $79.20. The stock's fifty day moving average price is $71.98 and its 200-day moving average price is $67.59.

CVS Health (NYSE:CVS - Get Free Report) last posted its earnings results on Thursday, July 31st. The pharmacy operator reported $1.81 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.46 by $0.35. The business had revenue of $98.92 billion for the quarter, compared to analysts' expectations of $94.87 billion. CVS Health had a net margin of 1.17% and a return on equity of 10.51%. The business's revenue for the quarter was up 8.4% compared to the same quarter last year. During the same quarter in the prior year, the business earned $1.83 EPS. CVS Health has set its FY 2025 guidance at 6.300-6.400 EPS. Sell-side analysts expect that CVS Health Corporation will post 5.89 earnings per share for the current year.

CVS Health Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Monday, November 3rd. Investors of record on Thursday, October 23rd will be given a dividend of $0.665 per share. The ex-dividend date is Thursday, October 23rd. This represents a $2.66 dividend on an annualized basis and a yield of 3.5%. CVS Health's dividend payout ratio is 74.30%.

Analyst Upgrades and Downgrades

CVS has been the topic of several research reports. Wolfe Research boosted their price objective on shares of CVS Health from $80.00 to $85.00 and gave the stock an "outperform" rating in a research note on Monday, September 22nd. Sanford C. Bernstein boosted their price target on CVS Health from $72.00 to $77.00 and gave the stock a "market perform" rating in a research report on Friday, September 5th. Morgan Stanley boosted their price target on CVS Health from $80.00 to $82.00 and gave the stock an "overweight" rating in a research report on Friday, August 1st. Mizuho boosted their price target on CVS Health from $76.00 to $88.00 and gave the stock an "outperform" rating in a research report on Thursday. Finally, Baird R W raised CVS Health from a "hold" rating to a "strong-buy" rating in a report on Thursday, August 14th. Two research analysts have rated the stock with a Strong Buy rating, nineteen have issued a Buy rating and four have given a Hold rating to the company. Based on data from MarketBeat.com, CVS Health has an average rating of "Moderate Buy" and an average target price of $79.80.

CVS Health Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.

Want to see what other hedge funds are holding CVS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CVS Health Corporation (NYSE:CVS - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.